Structured evidence table for Selenium Sleep Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Selenium Sleep Meta-Analysis | Previous treatments did not result in significant improvement of clinical symptoms. | 4 | Burgard Harald (2026) | Marked Clinical Improvement in Parkinson’s Disease Following Double-Filtration Apheresis: A Case Report |
| Selenium Sleep Meta-Analysis | Results showed increased values for LDL cholesterol (131 mg/dl), total cholesterol (219 mg/dl) while malondialdehyde-modified (MDA)-LDL a marker for fat oxidation was in the upper normal range (71 U/l), increased RANTES (Regulated And Normal T cell Expressed and Secreted) a marker for dental foci (58.4 ng/mL) and leaky gut with increased zonuline (48 ng/mL). | 4 | Burgard Harald (2026) | Marked Clinical Improvement in Parkinson’s Disease Following Double-Filtration Apheresis: A Case Report |
| Selenium Sleep Meta-Analysis | Excess immunoglobulin was found for laboratory allergy marker IgE (350 kU/l), while the antioxidative thiol status was decreased. | 4 | Burgard Harald (2026) | Marked Clinical Improvement in Parkinson’s Disease Following Double-Filtration Apheresis: A Case Report |
| Selenium Sleep Meta-Analysis | Based on recent studies, a potential role of the gut–brain axis in Parkinson’s disease can be supported. | 4 | Burgard Harald (2026) | Marked Clinical Improvement in Parkinson’s Disease Following Double-Filtration Apheresis: A Case Report |
Source documents